Related Experiment Video
Updated: May 5, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
[Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia]
1Department of Neurophysiology, Tokyo Medical University.
Abstract:
Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) is an autosomal dominant disease caused by mutations in the VCP gene. VCP encodes a well-conserved multifunctional protein, valosin containing protein (VCP), which has important roles in protein quality control via proteasome and autophagy, protein aggregation, quality control of mitochondria, cell proliferation, and so on. Clinically, muscle weakness is the most common symptom of which disease onset is around 40 years. Affected muscles are variable, and the patients are sometimes diagnosed as limb girdle muscular dystrophy or GNE myopathy. Muscle pathology shows characteristic features including cytoplasmic/nuclear inclusions, rimmed vacuoles, and disorganized myofibrills, together with neurogenic changes. Paget's disease of bone is reported to be observed in a half of the patients around the age of 40 years, but less common in Japanese patients. Frontotemporal dementia is seen around one third of the patients which appears nearly 10 years later than muscle or bone disease. In addition to cognitive dysfunctions, motor neuron involvement and cerebellar signs were also seen in our series. IBMPFD is not so rare disease as previously thought, but complicate clinical findings may make its diagnosis difficult.
Insights
Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD), caused by VCP gene mutations, presents with variable muscle weakness, bone disease, and dementia. Diagnosis can be challenging due to complex clinical findings.
Area of Science:
- Genetics
- Neurology
- Pathology
Background:
- Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) is an autosomal dominant disorder.
- Mutations in the VCP gene cause IBMPFD, affecting the valosin-containing protein (VCP) involved in cellular processes.
- VCP plays critical roles in protein quality control, protein aggregation, mitochondrial function, and cell proliferation.
Purpose of the Study:
- To summarize the clinical and pathological features of IBMPFD.
- To highlight the diagnostic challenges associated with this rare disease.
Main Methods:
- Review of clinical data and pathological findings in patients with IBMPFD.
- Analysis of the role of VCP gene mutations in disease pathogenesis.
Main Results:
- Muscle weakness is the most common symptom, with onset around age 40.
- Pathology reveals cytoplasmic/nuclear inclusions, rimmed vacuoles, and myofibrillar disorganization.
- Paget's disease of bone affects about half of patients, while frontotemporal dementia occurs in one-third, typically later.
Conclusions:
- IBMPFD is caused by VCP gene mutations and presents with a spectrum of symptoms including myopathy, bone disease, and dementia.
- The disease is not as rare as previously thought, but its varied presentation complicates diagnosis.
- Recognizing the diverse clinical manifestations is crucial for accurate and timely diagnosis.
More Related Videos
Related Concept Videos
Huntington Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll
Alzheimer Disease ll: Pathophysiology
Parkinson's Disease: Overview
Lysosomal Hydrolases

